Previous studies have shown that ERBB3 and AKT2 are key cell motility and proliferation regulators, respectively.19 We examined decreased expression of both ERBB3 and AKT2 in miR-148a-3p-treated bladder cancer cells at both the mRNA and protein levels (Figure 4b). The gene discussed is AKT2; the disease is urinary bladder carcinoma.